Literature DB >> 7143211

Moment analysis for the separation of mean in vivo disintegration, dissolution, absorption, and disposition time of ampicillin products.

Y Tanigawara, K Yamaoka, T Nakagawa, T Uno.   

Abstract

The in vivo disintegration, dissolution, absorption, and disposition processes of ampicillin products are separated by means of moment analysis. This method is model-independent, that is, any specific model is not assumed. The mean residence time (MRT), mean absorption time (MAT), mean dissolution time (MDT), and mean disintegration time (MDIT) are calculated for several dosage forms of ampicillin. The fraction of dose absorbed (F) is also separated into several fractions corresponding to these in vivo processes. Bioavailability and bioequivalence are discussed in terms of the zero and first moments. The flip-flop behavior of ampicillin is proved by the fact that the MRT following intravenous injection is less than the MAT of any oral dosage form. Absorption of released ampicillin is proved by the fact that the MRT following intravenous injection is less than the MAT of any oral dosage form. Absorption of released ampicillin is proved to be a rate-determining step, since the MRT of released ampicillin in the GI tract is the greatest of all MRT corresponding to the in vivo processes. Moment analysis is compared with classical compartment theory, and a new component concept is introduced.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7143211     DOI: 10.1002/jps.2600711013

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  11 in total

1.  Comparative evaluation of tableting compression behaviors by methods of internal and external lubricant addition: inhibition of enzymatic activity of trypsin preparation by using external lubricant addition during the tableting compression process.

Authors:  M Otsuka; M Sato; Y Matsuda
Journal:  AAPS PharmSci       Date:  2001

2.  Quantitative biopharmaceutics classification system: the central role of dose/solubility ratio.

Authors:  Eleni Rinaki; Georgia Valsami; Panos Macheras
Journal:  Pharm Res       Date:  2003-12       Impact factor: 4.200

Review 3.  Mean time parameters in pharmacokinetics. Definition, computation and clinical implications (Part II).

Authors:  P Veng-Pedersen
Journal:  Clin Pharmacokinet       Date:  1989-12       Impact factor: 6.447

4.  Local absorption kinetics of levofloxacin from intestinal tract into portal vein in conscious rat using portal-venous concentration difference.

Authors:  Y Fujieda; K Yamaoka; T Ito; T Nakagawa
Journal:  Pharm Res       Date:  1996-08       Impact factor: 4.200

5.  The sojourn time and its prospective use in pharmacology.

Authors:  G Segre
Journal:  J Pharmacokinet Biopharm       Date:  1988-12

6.  Effect of sodium bicarbonate amount on in vitro indomethacin release from self-setting carbonated-apatite cement.

Authors:  M Otsuka; Y Matsuda; Z Wang; J L Fox; W I Higuchi
Journal:  Pharm Res       Date:  1997-04       Impact factor: 4.200

7.  Physicochemical stability of cimetidine amorphous forms estimated by isothermal microcalorimetry.

Authors:  Makoto Otsuka; Fumie Kato; Yoshihisa Matsuda
Journal:  AAPS PharmSciTech       Date:  2002       Impact factor: 3.246

8.  Influence of tablet dissolution on furosemide bioavailability: a bioequivalence study.

Authors:  P J McNamara; T S Foster; G A Digenis; R B Patel; W A Craig; P G Welling; R S Rapaka; V K Prasad; V P Shah
Journal:  Pharm Res       Date:  1987-04       Impact factor: 4.200

9.  Linear systems analysis and moment analysis in the evaluation of bacampicillin bioavailability from microcapsule suspensions.

Authors:  M Nicklasson; K Ellström; R Sjöqvist; J Sjövall
Journal:  J Pharmacokinet Biopharm       Date:  1984-10

10.  Correlations between in vitro dissolution rate and bioavailability of alaproclate tablets.

Authors:  C Graffner; M Nicklasson; J E Lindgren
Journal:  J Pharmacokinet Biopharm       Date:  1984-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.